tiprankstipranks
Trending News
More News >
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
Japanese Market

COSMOS Pharmaceutical Corporation (3349) Ratios

Compare
1 Followers

COSMOS Pharmaceutical Corporation Ratios

JP:3349's free cash flow for Q4 2025 was ¥0.21. For the 2025 fiscal year, JP:3349's free cash flow was decreased by ¥ and operating cash flow was ¥0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.75 0.75 0.72 0.72 0.71
Quick Ratio
0.33 0.33 0.32 0.32 0.31
Cash Ratio
0.26 0.26 0.25 0.25 0.24
Solvency Ratio
0.20 0.20 0.18 0.18 0.20
Operating Cash Flow Ratio
0.00 0.24 0.25 0.26 0.28
Short-Term Operating Cash Flow Coverage
0.00 9.23 11.45 12.04 19.86
Net Current Asset Value
¥ -101.67B¥ -101.67B¥ -90.77B¥ -90.77B¥ -72.81B
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.10 0.07 0.07 0.04
Debt-to-Equity Ratio
0.19 0.19 0.15 0.15 0.09
Debt-to-Capital Ratio
0.16 0.16 0.13 0.13 0.08
Long-Term Debt-to-Capital Ratio
0.13 0.13 0.09 0.09 0.05
Financial Leverage Ratio
2.04 2.04 2.06 2.06 1.99
Debt Service Coverage Ratio
8.90 9.01 9.50 9.50 13.80
Interest Coverage Ratio
159.07 159.07 318.19 318.19 590.75
Debt to Market Cap
0.07 0.06 0.06 0.06 0.02
Interest Debt Per Share
633.52 633.52 431.12 431.12 230.46
Net Debt to EBITDA
-0.11 -0.11 -0.34 -0.34 -0.58
Profitability Margins
Gross Profit Margin
21.09%21.09%19.51%19.51%20.38%
EBIT Margin
4.16%4.21%3.50%3.50%3.97%
EBITDA Margin
6.35%6.41%5.57%5.57%5.74%
Operating Profit Margin
3.99%3.99%3.26%3.26%3.64%
Pretax Profit Margin
4.19%4.19%3.49%3.49%3.96%
Net Profit Margin
3.06%3.06%2.53%2.53%2.88%
Continuous Operations Profit Margin
3.06%3.06%2.53%2.53%2.88%
Net Income Per EBT
73.11%73.11%72.52%72.52%72.61%
EBT Per EBIT
104.87%104.87%107.04%107.04%108.78%
Return on Assets (ROA)
5.90%5.90%5.13%5.13%5.65%
Return on Equity (ROE)
12.55%12.03%10.57%10.57%11.27%
Return on Capital Employed (ROCE)
13.29%13.29%11.96%11.96%13.16%
Return on Invested Capital (ROIC)
9.47%9.47%8.47%8.47%9.37%
Return on Tangible Assets
5.91%5.91%5.14%5.14%5.66%
Earnings Yield
5.22%4.43%4.86%4.86%4.53%
Efficiency Ratios
Receivables Turnover
82.63 82.63 79.10 79.10 1.83K
Payables Turnover
4.51 4.51 4.33 4.33 4.07
Inventory Turnover
8.64 8.64 9.01 9.01 8.51
Fixed Asset Turnover
3.05 3.05 3.26 3.26 3.01
Asset Turnover
1.93 1.93 2.02 2.02 1.97
Working Capital Turnover Ratio
-16.33 -17.75 -16.95 -16.95 -16.30
Cash Conversion Cycle
-34.37 -34.37 -39.27 -39.27 -46.53
Days of Sales Outstanding
4.42 4.42 4.61 4.61 0.20
Days of Inventory Outstanding
42.22 42.22 40.50 40.50 42.91
Days of Payables Outstanding
81.00 81.00 84.38 84.38 89.65
Operating Cycle
46.64 46.64 45.11 45.11 43.11
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 661.99 662.13 696.30 687.32
Free Cash Flow Per Share
0.00 -10.84 -10.84 -8.01 98.46
CapEx Per Share
0.00 672.82 672.97 704.32 588.86
Free Cash Flow to Operating Cash Flow
0.00 -0.02 -0.02 -0.01 0.14
Dividend Paid and CapEx Coverage Ratio
0.00 0.90 0.90 0.91 1.09
Capital Expenditure Coverage Ratio
0.00 0.98 0.98 0.99 1.17
Operating Cash Flow Coverage Ratio
0.00 1.05 1.54 1.62 2.99
Operating Cash Flow to Sales Ratio
0.00 0.05 0.05 0.06 0.07
Free Cash Flow Yield
0.00%-0.12%-0.17%-0.13%1.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
19.09 22.60 20.56 20.56 22.07
Price-to-Sales (P/S) Ratio
0.58 0.69 0.52 0.52 0.63
Price-to-Book (P/B) Ratio
2.30 2.72 2.17 2.17 2.49
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -814.90 -585.31 -791.78 67.34
Price-to-Operating Cash Flow Ratio
0.00 13.34 9.58 9.11 9.65
Price-to-Earnings Growth (PEG) Ratio
3.65 0.85 7.60 7.60 7.95
Price-to-Fair Value
2.30 2.72 2.17 2.17 2.49
Enterprise Value Multiple
9.10 10.68 9.02 9.02 10.47
Enterprise Value
586.71B 692.92B 484.54B 484.54B 497.35B
EV to EBITDA
9.14 10.68 9.02 9.02 10.47
EV to Sales
0.58 0.69 0.50 0.50 0.60
EV to Free Cash Flow
0.00 -806.66 -564.07 -763.05 63.78
EV to Operating Cash Flow
0.00 13.21 9.24 8.78 9.14
Tangible Book Value Per Share
3.24K 3.24K 2.91K 2.91K 2.66K
Shareholders’ Equity Per Share
3.25K 3.25K 2.92K 2.92K 2.67K
Tax and Other Ratios
Effective Tax Rate
0.27 0.27 0.27 0.27 0.27
Revenue Per Share
12.76K 12.76K 12.18K 12.18K 10.45K
Net Income Per Share
390.86 390.86 308.61 308.61 300.48
Tax Burden
0.73 0.73 0.73 0.73 0.73
Interest Burden
1.01 0.99 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 1.69 1.69 2.26 1.66
Currency in JPY